Pregnancy

This educational video focuses on syphilis as an emerging threat to the health of birthing people and their infants. It provides guidance for prenatal nurses on understanding syphilis, interpreting diagnostic tests, educating patients, and implementing treatment strategies. The video emphasizes the importance of early detection, effective treatment with penicillin, partner testing, and follow-up testing to prevent serious complications such as stillbirth, congenital infection, and long-term developmental issues in newborns.

This counseling guide summarizes recommendations from the U.S. Department of Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission regarding the use of antiretroviral (ARV) drugs during pregnancy or when trying to conceive. Its purpose is to support informed, shared decision-making for individuals living with HIV and their clinicians. Effective antiretroviral therapy (ART) with sustained viral suppression is the cornerstone of maternal health and prevention of perinatal HIV transmission.

The 2024 US Preventive Services Task Force (USPSTF) Recommendation Statement reaffirms the importance of early screening for syphilis infection in all pregnant individuals to prevent congenital syphilis and associated complications. The report underscores timely testing—including repeat screening in high-risk cases—as a critical measure to safeguard maternal and infant health.

This report describes a newborn diagnosed with congenital syphilis, born to an adolescent mother without routine prenatal care. Despite initial diagnostic challenges, timely testing and treatment led to a positive outcome in accordance with national guidelines.

This fact sheet presents key talking points emphasizing the critical importance of administering the hepatitis B vaccine birth dose to newborns. 

This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.

This webpage highlights a recent study that reveals gaps in gonorrhea and chlamydia testing during pregnancy. It emphasizes the potential health risks these infections pose to both mother and child, urging the need for improved screening protocols. The study underscores the importance of regular prenatal testing to ensure better health outcomes for both.

This report outlines the progress made toward the elimination of mother-to-child transmission of hepatitis B virus in the Region of the Americas from 2012 to 2022. It highlights key strategies, achievements, and challenges in achieving the goal of reducing the transmission rates, providing a comprehensive overview of regional efforts to combat this public health issue.

This webpage provides the Vaccine Information Statement (VIS) for the hepatitis B vaccine, detailing the vaccine's purpose, the diseases it prevents, the recommended vaccination schedule, potential side effects, and important information for healthcare providers. It serves as an essential resource for understanding the importance of hepatitis B vaccination.

This webinar is about improving maternal health lessons learned from states addressing congenital syphilis.